Hasman Henrik, Aarestrup Frank M, Dalsgaard Anders, Guardabassi Luca
Danish Institute for Food and Veterinary Research, Copenhagen V, Denmark.
J Antimicrob Chemother. 2006 Apr;57(4):648-53. doi: 10.1093/jac/dkl033. Epub 2006 Feb 13.
The aim of the study was to determine whether glycopeptide resistance gene clusters from soil bacteria could be heterologously expressed in Enterococcus faecalis and adapt to the new host following exposure to vancomycin.
The vanHAX clusters from Paenibacillus thiaminolyticus PT-2B1, Paenibacillus apiarius PA-B2B and Amycolatopsis coloradensis DSM 44225 were separately cloned in an appropriately constructed shuttle vector containing the two-component regulatory system (vanRS) of Tn1546. The complete vanA(PT) operon (vanRSHAXY) from P. thiaminolyticus PT-2B1 was cloned in the same shuttle vector lacking enterococcal vanRS. All plasmid constructs were electroporated into E. faecalis JH2-2 and the MICs of vancomycin and teicoplanin were determined for each recombinant strain before and following exposure to sublethal concentrations of vancomycin.
The vanHAX clusters from P. thiaminolyticus and P. apiarius conferred high-level vancomycin resistance (MIC > or = 125 mg/L) in E. faecalis JH2-2. In contrast, cloning of the vanHAX cluster from A. coloradensis did not result in a significant increase of vancomycin resistance (MIC = 0.7 mg/L). Resistance to vancomycin was not observed after cloning the complete vanA(PT) operon from P. thiaminolyticus (MIC = 2 mg/L), but this recombinant rapidly adapted to high concentrations of vancomycin (MIC = 500 mg/L) following exposure to sub-lethal concentrations of this antibiotic.
The results showed that vanA(PT) in P. thiaminolyticus is a possible ancestor of vanA-mediated glycopeptide resistance in enterococci. Experimental evidence supported the hypothesis that enterococci did not acquire glycopeptide resistance directly from glycopeptide-producing organisms such as A. coloradensis.
本研究旨在确定土壤细菌中的糖肽抗性基因簇能否在粪肠球菌中异源表达,并在接触万古霉素后适应新宿主。
分别将解硫胺芽孢杆菌PT - 2B1、蜂房芽孢杆菌PA - B2B和科罗拉多拟无枝酸菌DSM 44225的vanHAX基因簇克隆到一个适当构建的穿梭载体中,该载体含有Tn1546的双组分调节系统(vanRS)。将解硫胺芽孢杆菌PT - 2B1的完整vanA(PT)操纵子(vanRSHAXY)克隆到缺少肠球菌vanRS的同一穿梭载体中。将所有质粒构建体电穿孔导入粪肠球菌JH2 - 2,并在每个重组菌株接触亚致死浓度的万古霉素之前和之后测定其对万古霉素和替考拉宁的最低抑菌浓度(MIC)。
解硫胺芽孢杆菌和蜂房芽孢杆菌的vanHAX基因簇在粪肠球菌JH2 - 2中赋予了高水平的万古霉素抗性(MIC≥125mg/L)。相比之下,克隆科罗拉多拟无枝酸菌的vanHAX基因簇并未导致万古霉素抗性显著增加(MIC = 0.7mg/L)。从解硫胺芽孢杆菌克隆完整的vanA(PT)操纵子后未观察到对万古霉素的抗性(MIC = 2mg/L),但该重组体在接触亚致死浓度的这种抗生素后迅速适应了高浓度的万古霉素(MIC = 500mg/L)。
结果表明,解硫胺芽孢杆菌中的vanA(PT)可能是肠球菌中vanA介导的糖肽抗性的祖先。实验证据支持了肠球菌并非直接从产糖肽的生物体如科罗拉多拟无枝酸菌获得糖肽抗性这一假说。